Which perioperative management strategies are safe and effective for patients who are taking oral anticoagulants?
Data sources Medline provided the primary data source with references from identified articles being reviewed for additional studies. The Cochrane Collaboration database was also searched and a search performed of cited references. Study selection Clinical studies, in English, examining perioperative management of patients receiving long-term oral anticoagulant (OAC) therapy were selected. Data extraction and synthesis Data were extracted regarding management strategy, thrombo-embolic events and bleeding complications, and type of surgical or invasive procedure. Event rates were reported as number of patients experiencing the event divided by number of patients at risk. Binomial and Poisson distributions were used to calculate 95% confidence intervals (CI). Results A total of 31 reports were identified and concluded to be of generally poor quality. For studies reporting thrombo-embolic events, 29 events occurred in 1868 patients (1.6%; 95% CI, 1.0-2.1) of which seven were strokes (0.4%; 95% CI, 0.0-0.7). Major bleeding while receiving OAC was reported to be rare for dental procedures (occurring in four out of 2014 individuals), arthrocentesis (in none out of 32), cataract surgery (none out of 203), and upper endoscopy or colonoscopy with or without biopsy (no occurrences in 111 patients). For the other invasive and surgical procedures reviewed, OAC needs to be withheld and a suitable personalised perioperative management strategy instigated. A guideline, based on the limited evidence available, for the perioperative management of anticoagulation for procedures requiring discontinuation of OAC is presented. Conclusions Certain surgical or invasive procedures can be undertaken in patients who are taking OAC therapy without alteration of their regimen. For procedures requiring discontinuation of OAC, personalised management strategies are required. More rigorous studies are needed to better inform this debate.
Commentary
This review examined 31 reports relating to invasive procedures in a number of disciplines. A small number of these reports documented oral surgery, whereas others covered procedures ranging from cataract surgery, cardiac catheterisation, gastrointestinal endoscopy to treatment of genitourinary conditions.
The quality of the reports was considered to be poor in general. A lack of separation of minor from major procedures was acknowledged to make the interpretation of postoperative problems difficult. In one report that included over 2000 procedures with continuation of OAC, 12 cases (0.6%) were recorded as suffering serious bleeding. Again, definition of serious compared with minor bleeding was not clarified. Another report, in which OAC were withheld in a group of over 500 cases, reported two thromboembolic events.
In two more recent studies, including over 100 cases, little difference was recorded in outcomes when OAC were withheld, with or without substitution with heparin regimes. A higher than expected observed rate of thrombo-embolic events and strokes associated with various forms of surgery was noted in these two studies. Theoretical causative factors such as rebound hypercoagulability and a thrombotic state induced by surgery were discussed but other possible factors, such as the effects of drugs (eg, antibiotics and analgesics) and of change of diet, were not.
If it is accepted that only minor surgery is being performed in dental practice, the relevance of this paper to general dental practitioners is limited. Perhaps its significance is that it highlights the possibly grave consequences of a thrombo embolic event compared with the consequence of even a serious postoperative bleed. Therefore if planning a minor surgical procedure in a patient with a mechanical mitral valve, who is maintained at the higher INR (international normalized ratio) level withholding OAC is not warranted unless it is required on medical grounds (to maintain them in their target/therapeutic range). Ironically, the lower-target patients, such as the atrial fibrillation group, who are less likely to bleed, can have their OAC stopped with little consequence. This paper produces no evidence to support the use of regimens of heparin to substitute for perioperatively withheld OAC in minor surgical procedures.
Practice points
Dental surgery including minor oral surgical procedures should be performed without alteration of OAC.
Heparin substituting for OAC withheld perioperatively in minor oral surgery is not supported at the present time.
